Results 231 to 240 of about 50,915 (302)

Integrative Proteomic and Metabolomic Analyses Reveal Arginase-1-Mediated Nitrogen Metabolic Reprogramming Associated with Growth Advantage in Ronglai Binary Hybrid Pigs. [PDF]

Animals (Basel)
Yang W, Wu L, Xie H, Zhang D, Wang Y, Pan J, Xu X, Bai X, Zhang W, Zheng Y.   +9 more
europepmc   +1 more source

Mechanism of Si Ni Decoction in Stabilizing Atherosclerotic Plaques in the Lower Extremities by Regulating Macrophage Polarization via NCOR1 Mitophagy

Immunity, Inflammation and Disease, Volume 14, Issue 10, October 2026.
ABSTRACT Introduction Si Ni decoction (SND) is known for its anti‐inflammatory, immune‐regulating, and microcirculation‐improving effects. However, the molecular mechanisms underlying its role in atherosclerosis (AS) remain unclear. It aimed to explore the mechanisms by which SND stabilizes lower extremity atherosclerotic plaques through the regulation
Zhe Liu, Shuhui Ge, Jianfei Yang, Ying Zhou, Li Jin, Yudong Fang   +5 more
wiley   +1 more source

Differential Expression and Function of Arginase in Mouse Uterus During Early Pregnancy. [PDF]

Int J Mol Sci
Wang ZM, Shen QM, Luo HN, Yang HY, Lu J, Yang ZM.   +5 more
europepmc   +1 more source

Curcumin Improves Silica Induced Lung Fibrosis by Targeting TLR4‐NLRP3 Inflammasome and TGF‐β Inhibition in Mice Model

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 10, October 2026.
ABSTRACT Silicosis, a progressive occupational lung disease, caused by inhalation of crystalline silica particles, leads to chronic inflammation and pulmonary fibrosis. Increasing evidence suggests that activation of the TLR4/NF‐κB signaling pathway and NLRP3 inflammasome plays a crucial role in silica‐induced lung injury.
Sneha Kumari, Payal Singh, D. Dash, Rashmi Singh   +3 more
wiley   +1 more source

Clinical and Haematologic Correlates of Soluble VCAM‐1 in Adults With Steady‐State Sickle Cell Disease

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Background Endothelial activation contributes to the vasculopathy of sickle cell disease (SCD). We evaluated serum soluble vascular cell adhesion molecule‐1 (sVCAM‐1), a surrogate marker of endothelial activation, and examined its clinical and haematologic correlates in adults with steady‐state SCD.
William Kwesi Ghunney, Eugenia Vicky Asare, John Benaiah Ayete‐Nyampong, Wonder Doku‐Agama, Eric Kyei‐Baafour, Michael Fokou Ofori, George Obeng Adjei, Edeghonghon Olayemi   +7 more
wiley   +1 more source

Involvement of increased arginase-1^<b>+</b> group 2 innate lymphoid cells and myeloid-derived suppressor cells in endometrial carcinoma: A pilot study. [PDF]

J Int Med Res
Gong Z, Lu Z, Pan A, Wang H, Yi H, Guo P, Bi K, Li X, Chen Y, Xu Y, Cao Y, Li C, Jiang H.   +12 more
europepmc   +1 more source

The Clinicopathological Characteristics and Prognosis of Cholangiolocarcinoma: A Multicenter Study With a Central Pathology Review

Journal of Hepato-Biliary-Pancreatic Sciences, Volume 33, Issue 10, Page 758-768, October 2026.
Highlight Ishii and colleagues conducted the first nationwide, centrally reviewed study of cholangiolocarcinoma, clarifying its distinct clinicopathological identity: apical epithelial membrane antigen expression, low viral hepatitis prevalence, and favorable long‐term survival (10‐year overall survival of 73.7%).
Takamichi Ishii, Kenta Makino, Etsuro Hatano, Mina Komuta, Jun Akiba, Yoshihiro Sakamoto, Shun‐Ichi Ariizumi, Goro Honda, Toru Hisaka, Yutaka Takeda, Akira Shimizu, Kentaro Yasuchika, Takashi Mizuno, Daisuke Asano, Atsushi Fujio, Naoto Gotohda, Chie Kitami, Koji Amaya, Hiroshi Sadamori, Manabu Kawai, Akiyoshi Nakakura, Masafumi Nakamura, Itaru Endo   +22 more
wiley   +1 more source

Efficacy and safety of pegzilarginase in patients below 2 years of age with arginase 1 deficiency: a phase 3, open-label, multi-centre study. [PDF]

EClinicalMedicine
Ghosh A, Baghdasaryan A, Pinto PL, Rudebeck M.   +3 more
europepmc   +1 more source

Targeting Arginase 1 but Not Arginase 2 Protects from Myocardial Ischemia-Reperfusion Injury via Nitric Oxide Signaling by Red Blood Cells in Type 2 Diabetes. [PDF]

Antioxidants (Basel)
Yang J, Tratsiakovich Y, Cao R, Mahdi A, Pironti G, Jiao T, Humoud R, Kontidou E, Tengbom J, Collado A, Zhou Z, Cao Y, Köhler E, Mullick AE, Pernow J.   +14 more
europepmc   +1 more source